Anthony S. Fauci

Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling

Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by SARS-CoV-2 coronavirus are now enrolling healthy adults at clinical trial sites in the United States.